Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial - PubMed (original) (raw)

Randomized Controlled Trial

doi: 10.1186/1741-7015-11-164.

Mònica Bulló, Miguel Ángel Martínez-González, Emilio Ros, Dolores Corella, Ramon Estruch, Montserrat Fitó, Fernando Arós, Julia Wärnberg, Miquel Fiol, José Lapetra, Ernest Vinyoles, Rosa Maria Lamuela-Raventós, Lluís Serra-Majem, Xavier Pintó, Valentina Ruiz-Gutiérrez, Josep Basora, Jordi Salas-Salvadó; PREDIMED study group

Collaborators, Affiliations

Randomized Controlled Trial

Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial

Marta Guasch-Ferré et al. BMC Med. 2013.

Abstract

Background: Prospective studies in non-Mediterranean populations have consistently related increasing nut consumption to lower coronary heart disease mortality. A small protective effect on all-cause and cancer mortality has also been suggested. To examine the association between frequency of nut consumption and mortality in individuals at high cardiovascular risk from Spain, a Mediterranean country with a relatively high average nut intake per person.

Methods: We evaluated 7,216 men and women aged 55 to 80 years randomized to 1 of 3 interventions (Mediterranean diets supplemented with nuts or olive oil and control diet) in the PREDIMED ('PREvención con DIeta MEDiterránea') study. Nut consumption was assessed at baseline and mortality was ascertained by medical records and linkage to the National Death Index. Multivariable-adjusted Cox regression and multivariable analyses with generalized estimating equation models were used to assess the association between yearly repeated measurements of nut consumption and mortality.

Results: During a median follow-up of 4.8 years, 323 total deaths, 81 cardiovascular deaths and 130 cancer deaths occurred. Nut consumption was associated with a significantly reduced risk of all-cause mortality (P for trend<0.05, all). Compared to non-consumers, subjects consuming nuts>3 servings/week (32% of the cohort) had a 39% lower mortality risk (hazard ratio (HR) 0.61; 95% CI 0.45 to 0.83). A similar protective effect against cardiovascular and cancer mortality was observed. Participants allocated to the Mediterranean diet with nuts group who consumed nuts>3 servings/week at baseline had the lowest total mortality risk (HR 0.37; 95% CI 0.22 to 0.66).

Conclusions: Increased frequency of nut consumption was associated with a significantly reduced risk of mortality in a Mediterranean population at high cardiovascular risk.Please see related commentary: http://www.biomedcentral.com/1741-7015/11/165.

Trial registration: Clinicaltrials.gov. International Standard Randomized Controlled Trial Number (ISRCTN): 35739639. Registration date: 5 October 2005.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Adjusted hazard ratios of total mortality by frequency of nut consumption and intervention group. The Cox regression models were adjusted for age in years, sex, BMI in kg/m2, smoking status (never, former, current smoker), educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity in MET-min/day, history of diabetes (yes/no), history of hypercholesterolemia (yes/no), use of oral antidiabetic medication (yes/no), use of antihypertensive medication (yes/no), use of statins (yes/no), total energy intake (kcal/d), dietary variables in quintiles (vegetables, fruits, red meat, eggs and fish), alcohol intake (continuous, adding a quadratic term), and Mediterranean diet adherence (13-point score). The model was stratified by recruitment centre. Extremes of total energy intake were excluded. Values for the two upper categories of nut consumption are 0.38 (95% CI: 0.23 to 0.63) and 0.37 (95% CI: 0.22 to 0.66) in the Mediterranean diet supplemented with nuts (MedDiet + NUTS) group; 0.79 (95% CI: 0.50 to 1.24) and 0.63 (95% CI: 0.36 to 1.1) in the Mediterranean diet supplemented with extra-virgin olive oil (MedDiet + EVOO) group; and 1.04 (95% CI: 0.64 to 1.69) and 0.84 (95% CI: 0.48 to 1.44) in the low-fat control diet group. P for the interaction between baseline nut consumption and intervention group= 0.019. P for trend: MedDiet + NUTS, p=0.01; MedDiet + EVOO, p=0.15; Control diet, p=0.42.

Comment in

Similar articles

Cited by

References

    1. Ros E, Mataix J. Fatty acid composition of nuts-implications for cardiovascular health. Br J Nutr. 2006;96:S29–S35. doi: 10.1017/BJN20061861. - DOI - PubMed
    1. Segura R, Javierre C, Lizarraga MA, Ros E. Other relevant components of nuts: phytosterols, folate and minerals. Br J Nutr. 2006;96:S36–S44. doi: 10.1017/BJN20061862. - DOI - PubMed
    1. Salas-Salvado J, Bullo M, Perez-Heras A, Ros E. Dietary fibre, nuts and cardiovascular diseases. Br J Nutr. 2006;96:S46–S51. doi: 10.1079/BJN20061700. - DOI - PubMed
    1. Ros E, Tapsell LC, Sabate J. Nuts and berries for heart health. Curr Atheroscler Rep. 2010;12:397–406. doi: 10.1007/s11883-010-0132-5. - DOI - PubMed
    1. Ros E. Health benefits of nut consumption. Nutrients. 2010;2:652–682. doi: 10.3390/nu2070652. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources